chlorpromazine 50 mg
INDICATIONS AND USAGE For the management of manifestations of psychotic disorders. For the treatment of schizophrenia. To control nausea and vomiting. For relief of restlessness and apprehension before surgery. For acute intermittent porphyria. As an adjunct in the treatment of tetanus. To control the manifestations of the manic type of manic-depressive illness. For relief of intractable hiccups. For the treatment of severe behavioral problems in children (1 to 12 years of age) marked by combativeness and/or explosive hyperexcitable behavior (out of proportion to immediate provocations), and in the short-term treatment of hyperactive children who show excessive motor activity with accompanying conduct disorders consisting of some or all of the following symptoms: impulsivity, difficulty sustaining attention, aggressivity, mood lability and poor frustration tolerance.
sandoz inc
ROUND BROWN GG 407 50
GG 407 50 ROUND BROWN
Related Pills
chlorpromazine 200 mg
sandoz inc
chlorpromazine 100 mg
sandoz inc
Chlorpromazine 25 mg
Sandoz Inc
Chlorpromazine 10 mg
Sandoz Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Chlorpromazine hydrochloride tablets, USP are available as: 10 mg: round, film-coated, butterscotch colored tablets, debossed GG 455 on one side and 10 on the reverse side, and supplied as: NDC 0781-1715-01 bottles of 100 NDC 0781-1715-10 bottles of 1000 NDC 0781-1715-13 unit dose packages of 100 25 mg: round, film-coated, butterscotch colored tablets, debossed GG 476 on one side and 25 on the reverse side, and supplied as: NDC 0781-1716-01 bottles of 100 NDC 0781-1716-10 bottles of 1000 NDC 0781-1716-13 unit dose packages of 100 50 mg: round, film-coated, butterscotch colored tablets, debossed GG 407 on one side and 50 on the reverse side, and supplied as: NDC 0781-1717-01 bottles of 100 NDC 0781-1717-10 bottles of 1000 NDC 0781-1717-13 unit dose packages of 100 For use only in severe neuropsychiatric conditions: 100 mg: round, film-coated, butterscotch colored tablets, debossed GG 437 on one side and 100 on the reverse side, and supplied as: NDC 0781-1718-01 bottles of 100 NDC 0781-1718-10 bottles of 1000 NDC 0781-1718-13 unit dose packages of 100 200 mg: round, film-coated, butterscotch colored tablets, debossed GG 457 on one side and 200 on the reverse side, and supplied as: NDC 0781-1719-01 bottles of 100 NDC 0781-1719-10 bottles of 1000 NDC 0781-1719-13 unit dose packages of 100 Store at 20°-25°C (68°-77°F) (see USP Controlled Room Temperature). Protect from moisture. Dispense in a tight, light-resistant container.
More pills like ROUND GG 407 50